The iShares Biotechnology ETF (IBB) provides exposure to healthcare innovation with a focus on the biggest firms by market ...

Biotech ETFs offer investors exposure to the most innovative and growth-oriented industry within the traditionally defensive ...

Biotech ETFs offer diversified exposure to multiple biotech stocks ... technology, and marijuana. Prior to The Motley Fool, Keith was CEO of Constant Care Technology, a healthcare technology company; ...

Launched on 06/23/2005, the Invesco Biotechnology & Genome ETF (PBE) is a smart beta exchange traded fund offering broad exposure to the Health Care ETFs category of the market. What Are Smart Beta ...

IBB offers diversified exposure to the biotech sector, focusing on large-cap leaders while maintaining positions in smaller ...

Biotech ETFs have had a banner year, earning some investors returns north of 30 percent since January. I say “some investors” because, it turns out, not all biotech ETFs are created equal. In our 2012 ...

The SPDR S&P Biotech ETF (XBI) was launched on 01/31/2006, and is a smart beta exchange traded fund designed to offer broad exposure to the Health Care ETFs category of the market. Products that are ...

Diversify Outside the U.S. Heavyweights: Global healthcare ETFs like iShares Global Healthcare ETF (NYSE: MIXJ) provide ...

Wealth Enhancement Advisory Services LLC increased its position in shares of Invesco Biotechnology & Genome ETF (NYSEARCA:PBE – Free Report) by 10.6% during the fourth quarter, according to the ...